These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22276953)

  • 21. Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma.
    Swedberg JE; Wu G; Mahatmanto T; Durek T; Caradoc-Davies TT; Whisstock JC; Law RHP; Craik DJ
    J Med Chem; 2019 Jan; 62(2):552-560. PubMed ID: 30520638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method.
    Patterson AW; Wood WJ; Hornsby M; Lesley S; Spraggon G; Ellman JA
    J Med Chem; 2006 Oct; 49(21):6298-307. PubMed ID: 17034136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone.
    Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE
    J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bovine protein C inhibitor has a unique reactive site and can transiently inhibit plasmin.
    Yuasa H; Tanaka H; Hayashi T; Wakita T; Nakamura H; Nishioka J; Kawarada Y; Suzuki K
    Thromb Haemost; 2000 Feb; 83(2):262-7. PubMed ID: 10739384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J; Mucha A; Cierpicki T; Kafarski P
    J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationship.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Okamoto U; Hijikata-Okunomiya A; Okamoto S
    Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):1964-72. PubMed ID: 11145152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of positional-scanning libraries of fluorogenic peptide substrates to define the extended substrate specificity of plasmin and thrombin.
    Backes BJ; Harris JL; Leonetti F; Craik CS; Ellman JA
    Nat Biotechnol; 2000 Feb; 18(2):187-93. PubMed ID: 10657126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design.
    Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ
    J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4-Heterocyclohexanone-based inhibitors of the serine protease plasmin.
    Sanders TC; Seto CT
    J Med Chem; 1999 Jul; 42(15):2969-76. PubMed ID: 10425106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CU-2010--a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties.
    Dietrich W; Nicklisch S; Koster A; Spannagl M; Giersiefen H; van de Locht A
    Anesthesiology; 2009 Jan; 110(1):123-30. PubMed ID: 19104179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of new NAPAP-analogs.
    Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
    J Enzyme Inhib Med Chem; 2002 Apr; 17(2):241-9. PubMed ID: 12420761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C2-symmetric macrocyclic carbohydrate/amino acid hybrids through copper(I)-catalyzed formation of 1,2,3-triazoles.
    Billing JF; Nilsson UJ
    J Org Chem; 2005 Jun; 70(12):4847-50. PubMed ID: 15932327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs.
    Colgrave ML; Korsinczky MJ; Clark RJ; Foley F; Craik DJ
    Biopolymers; 2010; 94(5):665-72. PubMed ID: 20564016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Structural Characterization of Macrocyclic Plasmin Inhibitors.
    Wiedemeyer SJA; Wu G; Pham TLP; Lang-Henkel H; Perez Urzua B; Whisstock JC; Law RHP; Steinmetzer T
    ChemMedChem; 2023 Mar; 18(6):e202200632. PubMed ID: 36710259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability.
    Staas DD; Savage KL; Sherman VL; Shimp HL; Lyle TA; Tran LO; Wiscount CM; McMasters DR; Sanderson PE; Williams PD; Lucas BJ; Krueger JA; Lewis SD; White RB; Yu S; Wong BK; Kochansky CJ; Anari MR; Yan Y; Vacca JP
    Bioorg Med Chem; 2006 Oct; 14(20):6900-16. PubMed ID: 16870455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.
    Whiting M; Tripp JC; Lin YC; Lindstrom W; Olson AJ; Elder JH; Sharpless KB; Fokin VV
    J Med Chem; 2006 Dec; 49(26):7697-710. PubMed ID: 17181152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
    Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting subsite interactions of plasmin with substrates and inhibitors through computational docking analysis.
    Gohda K; Teno N; Wanaka K; Tsuda Y
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):571-7. PubMed ID: 21992704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.